Number of Seats/Users: QUOSA offers discounts based on the number of users or seats. A higher volume typically leads to a better discount structure, especially for enterprise-level usage.

Commitment to a Long-Term Contract: Discounts are often provided to companies that commit to using the service for a longer period (e.g., 1-year or 3-year contracts). A longer commitment shows QUOSA that the company is serious and willing to invest in the platform long-term.

No Active Discounts: Companies that are not already receiving other active discounts may have a better chance of qualifying for additional discounts from QUOSA. QUOSA reserves discounts for new customers or those not currently under promotional pricing.

Volume or Usage Commitment: QUOSA offers discounts if you agree to a minimum amount of usage or transaction volume. This could be based on data storage, transactions, or other metrics tied to how much you will use the platform.

Enterprise-Level Negotiation: Companies that qualify as “enterprise” due to their size or complexity (e.g., having large teams, multiple departments, or geographical presence) may be eligible for additional discounts from QUOSA. Such companies are often in a position to negotiate for better pricing.

Early Renewal or Prepayment: QUOSA often offers discounts if you renew early or prepay for the entire contract period. This is a common approach to securing a lower price.

Here at Spendbase, our internal data shows that QUOSA has been a valuable tool for centralizing and managing scientific literature, particularly in the life sciences sector. Our clients have highlighted several key aspects of their experience with QUOSA:

Strengths:

• Centralized Literature Management: Clients appreciate QUOSA’s ability to consolidate scientific information, streamlining the process of collecting and sharing knowledge.

• Integration with Databases: The partnership between EMBASE.com and QUOSA has been noted for enhancing productivity by facilitating seamless navigation from search results to full-text articles.

• Support for Pharmacovigilance: The launch of QUOSA PV has been recognized for improving literature monitoring for pharmacovigilance, aiding in efficient and compliant use of scientific information.

Areas for Improvement:

• Discontinuation Concerns: Clients have expressed concerns regarding the discontinuation of QUOSA in June 2023, necessitating the search for alternative literature management tools.

• Transition Challenges: The need to transition to new systems has been identified as a challenge, with clients seeking solutions that can replicate existing workflows and maintain efficiency.

In summary, while QUOSA has been instrumental in managing scientific literature effectively, the upcoming discontinuation has prompted our clients to explore alternative solutions to ensure continuity and compliance in their literature management processes.